Health care workers during a Covid-19 screening drive at Goregaon in Mumbai.(Satyabrata Tripathy/HT PHOTO)

India’s mRNA vaccine candidate advances to human trial phase

New Delhi, Hindustan Times | By Anonna Dutt
UPDATED ON DEC 12, 2020 02:56 PM IST
An mRNA vaccine uses a synthetic RNA (genetic material) encoded with instructions to make specific proteins of the Sars-CoV-2 virus so that the body can generate an immune response without getting the disease.
Story Saved